Company Profile
IQVIA Stock Price, News & Analysis
- Ticker:
- IQV
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
232.43 USD (-1.53%)
Close
Last updated: August 6, 2026
30.1B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IQV closed down 1.53% at $232.43. No new same-company headline was identified in the current news window.
Company overview
Business overview
IQVIA is a healthcare data, analytics, and contract research company that supports pharmaceutical development and commercialization. It is a critical infrastructure name for the drug-development ecosystem rather than a therapeutic developer.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, IQVIA has a global footprint across clinical, commercial, and real-world data services. It sits in healthcare services and research infrastructure.
Business Model Characteristics
The company earns revenue from contract research, data analytics, technology-enabled services, and life sciences consulting. Investors focus on clinical demand, services growth, and the health of biopharma R&D budgets.
Position Within the Biotechnology Landscape
IQVIA sits inside the biotech ecosystem as a services and data platform. It is not binary like a drug stock, but it is highly relevant because it benefits from and helps enable drug development activity.
Future catalysts
IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of IQVIA (IQV)?
IQVIA (IQV) most recently closed at 232.43 USD, a -1.53% move versus the previous session.
What is the market cap of IQVIA (IQV)?
IQVIA currently has a market capitalization of 30.1B USD on BioPharmSignal.
What does IQVIA do?
IQVIA is a healthcare data, analytics, and contract research company that supports pharmaceutical development and commercialization. It is a critical infrastructure name for the drug-development ecosystem rather than a therapeutic developer.
On which exchange is IQV stock listed?
IQVIA (IQV) is associated with NYSE, United States, Biopharma.
What is AI-enabled?
IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work.
Which conditions is IQVIA targeting with AI-enabled?
IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work.
How does IQVIA describe recent progress with AI-enabled?
IQVIA’s key catalyst is still clinical-outsourcing demand, with bookings, backlog conversion, and AI-enabled service productivity doing most of the work.
What is That?
IQVIA is a healthcare data, analytics, and contract research company that supports pharmaceutical development and commercialization.